ID AK2_ARATH Reviewed; 544 AA. AC O23653; Q9FMU4; Q9FY44; DT 05-SEP-2006, integrated into UniProtKB/Swiss-Prot. DT 05-SEP-2006, sequence version 2. DT 16-JUN-2009, entry version 54. DE RecName: Full=Aspartokinase 2, chloroplastic; DE EC=2.7.2.4; DE AltName: Full=Aspartate kinase 2; DE Flags: Precursor; GN Name=AK2; Synonyms=AK-LYS2, CARAB-AK-LYS; OrderedLocusNames=At5g14060; GN ORFNames=MUA22.6; OS Arabidopsis thaliana (Mouse-ear cress). OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta; OC Spermatophyta; Magnoliophyta; eudicotyledons; core eudicotyledons; OC rosids; eurosids II; Brassicales; Brassicaceae; Arabidopsis. OX NCBI_TaxID=3702; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RX MEDLINE=97351562; PubMed=9207844; DOI=10.1023/A:1005849228945; RA Tang G., Zhu-Shimoni J.X., Amir R., Zchori I.B.-T., Galili G.; RT "Cloning and expression of an Arabidopsis thaliana cDNA encoding a RT monofunctional aspartate kinase homologous to the lysine-sensitive RT enzyme of Escherichia coli."; RL Plant Mol. Biol. 34:287-293(1997). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=cv. Columbia; TISSUE=Leaf; RA Frankard V.M.S., Vauterin M., Jacobs M.; RL Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=cv. Columbia; RX MEDLINE=98162728; PubMed=9501997; DOI=10.1093/dnares/4.6.401; RA Nakamura Y., Sato S., Kaneko T., Kotani H., Asamizu E., Miyajima N., RA Tabata S.; RT "Structural analysis of Arabidopsis thaliana chromosome 5. III. RT Sequence features of the regions of 1,191,918 bp covered by seventeen RT physically assigned P1 clones."; RL DNA Res. 4:401-414(1997). RN [4] RP BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION. RX PubMed=17140415; DOI=10.1111/j.1742-4658.2006.05573.x; RA Curien G., Laurencin M., Robert-Genthon M., Dumas R.; RT "Allosteric monofunctional aspartate kinases from Arabidopsis."; RL FEBS J. 274:164-176(2007). CC -!- FUNCTION: Involved in the first step of essential amino acids CC lysine, threonine, methionine and isoleucine synthesis via the CC aspartate-family pathway. CC -!- CATALYTIC ACTIVITY: ATP + L-aspartate = ADP + 4-phospho-L- CC aspartate. CC -!- ENZYME REGULATION: Allosterically inhibited by lysine, but not by CC S-adenosyl-L-methionine (SAM). K(0.5) for lysine in the presence CC of physiological concentrations of substrates is 12.5 uM. No CC inhibition by threonine or leucine and no activation or inhibition CC by alanine, cysteine, isoleucine, serine, valine, methionine, CC glutamine, asparagine, glutamic acid or arginine. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=980 uM for ATP; CC KM=1940 uM for aspartate; CC Note=K(cat) is 14.5/sec; CC -!- PATHWAY: Amino-acid biosynthesis; L-lysine biosynthesis via DAP CC pathway; tetrahydrodipicolinate from L-aspartate: step 1/4. CC -!- PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de CC novo pathway; L-homoserine from L-aspartate: step 1/3. CC -!- PATHWAY: Amino-acid biosynthesis; L-threonine biosynthesis; L- CC threonine from L-aspartate: step 1/5. CC -!- SUBCELLULAR LOCATION: Plastid, chloroplast (Potential). CC -!- TISSUE SPECIFICITY: Expressed in stems, leaves, floral organs and CC young seedlings. CC -!- SIMILARITY: Belongs to the aspartokinase family. CC -!- SIMILARITY: Contains 2 ACT domains. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; U62020; AAB63104.1; -; mRNA. DR EMBL; Y16255; CAC06395.1; -; Genomic_DNA. DR EMBL; AB007650; BAB08285.1; -; Genomic_DNA. DR IPI; IPI00527711; -. DR RefSeq; NP_001078581.1; -. DR RefSeq; NP_196910.1; -. DR UniGene; At.21761; -. DR SMR; O23653; 80-542. DR PRIDE; O23653; -. DR GeneID; 831255; -. DR GenomeReviews; BA000015_GR; AT5G14060. DR KEGG; ath:AT5G14060; -. DR NMPDR; fig|3702.1.peg.23535; -. DR TAIR; At5g14060; -. DR OMA; O23653; KLSCLFM. DR BRENDA; 2.7.2.4; 302. DR GermOnline; AT5G14060; Arabidopsis thaliana. DR GO; GO:0009507; C:chloroplast; IEA:UniProtKB-SubCell. DR GO; GO:0016597; F:amino acid binding; IEA:InterPro. DR GO; GO:0004072; F:aspartate kinase activity; IEA:EC. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0009088; P:threonine biosynthetic process; IEA:UniProtKB-KW. DR InterPro; IPR002912; ACT_bd. DR InterPro; IPR001048; Asp/Glu/Uridylate_kinase. DR InterPro; IPR001341; Asp_kin_reg. DR InterPro; IPR018042; Aspartate_kinase_CS. DR Gene3D; G3DSA:3.40.1160.10; Aa_kinase; 1. DR Pfam; PF00696; AA_kinase; 1. DR Pfam; PF01842; ACT; 2. DR TIGRFAMs; TIGR00657; asp_kinases; 1. DR PROSITE; PS00324; ASPARTOKINASE; 1. PE 1: Evidence at protein level; KW Amino-acid biosynthesis; ATP-binding; Chloroplast; Complete proteome; KW Kinase; Nucleotide-binding; Plastid; Repeat; Threonine biosynthesis; KW Transferase; Transit peptide. FT TRANSIT 1 84 Chloroplast (Potential). FT CHAIN 85 544 Aspartokinase 2, chloroplastic. FT /FTId=PRO_0000248158. FT DOMAIN 402 477 ACT 1. FT DOMAIN 478 539 ACT 2. FT BINDING 87 87 ATP (By similarity). FT BINDING 90 90 ATP; via amide nitrogen (By similarity). FT BINDING 119 119 ATP (By similarity). FT BINDING 203 203 Substrate (By similarity). FT CONFLICT 94 94 E -> G (in Ref. 1; AAB63104 and 2; FT CAC06395). FT CONFLICT 107 107 L -> F (in Ref. 1; AAB63104 and 2; FT CAC06395). FT CONFLICT 125 125 T -> I (in Ref. 1; AAB63104 and 2; FT CAC06395). FT CONFLICT 144 144 E -> G (in Ref. 1; AAB63104). SQ SEQUENCE 544 AA; 59605 MW; 7DBCFDC1138645AC CRC64; MASLQLYGVK TPGLALSSKR LEFASKGACF SVTLPSSSAV FRDVEHSCRN IGLRVSCEAL RVDLLQRKEP ETCDSSGTGK ELTCVMKFGG SSVESAERMK EVANLILSFP DERPVIVLSA MGKTTNKLLK AGEKAVTCGV TNVESIEELS FIKELHLRTA HELGVETTVI EKHLEGLHQL LKGISMMKEL TLRTRDYLVS FGECMSTRLF SAYLNKIGHK ARQYDAFEIG FITTDDFTNA DILEATYPAV SKTLVGDWSK ENAVPVVTGY LGKGWRSCAI TTLGRGGSDL TATTIGKALG LREIQVWKDV DGVLTCDPNI YPGAQSVPYL TFDEAAELAY FGAQVLHPLS MRPARDGDIP VRVKNSYNPT APGTVITRSR DMSKAVLTSI VLKRNVTMLD IASTRMLGQY GFLAKVFTTF EDLGISVDVV ATSEVSISLT LDPAKLWGRE LIQRVNELDN LVEELEKIAV VKLLQRRSII SLIGNVQKSS LILEKVFQVF RSNGVNVQMI SQGASKVNIS LIVNDEEAEQ CVRALHSAFF ETDP //